
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Recipient : Biovaxys
Deal Size : Undisclosed
Deal Type : Collaboration
BioVaxys & Sona Nanotech Enter Research Collaboration
Details : Through the collaboration, BioVaxys will leverage it's DPX Immune Educating Platform in combination with Sona’s Targeted Hyperthermia Therapy to treat solid tumors.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 07, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Recipient : Biovaxys
Deal Size : Undisclosed
Deal Type : Collaboration
